Clinical Trials Logo

Filter by:
NCT ID: NCT05715554 Completed - Post-COVID Syndrome Clinical Trials

Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients

Start date: August 6, 2022
Phase: N/A
Study type: Interventional

A growing number of studies identify a spectrum of persistent symptoms experienced by COVID-19 patients for months after recovery. Symptoms include cough, fatigue, dyspnea, pain, and brain fog (cognitive impairment, including confusion and memory loss), which have a negative impact on daily activities. Homoeopathic practitioners from around the world have documented a number of successful cases of Post COVID treatment. Even though evidence from practice-based research is limited, the purpose of the current study was to evaluate the effect of individualized homoeopathy treatment on post-COVID syndrome.

NCT ID: NCT05711784 Completed - Clinical trials for Body Weight in the Overweight and Obese Class - I Population

A Clinical Safety and Efficacy Study in Subjects With Overweight or Obese Class - I, to Evaluate the Degree of Significant Weight Loss by Regular Intake of Phaseolean (White Kidney Bean Standardized Extract)

Start date: February 22, 2023
Phase: N/A
Study type: Interventional

A randomized, double-blinded, placebo-controlled, single-centre, clinical safety and efficacy study in subjects with overweight or Obese Class - I, to evaluate the degree of significant weight loss by regular intake of Phaseolean (White Kidney Bean Standardized Extract). This study is dose-response study to evaluate effectiveness of two different dosage i.e. 1500 mg Versus 3000 mg. 22 subjects will be enrolled per test treatment to complete 20 subjects per test treatment.

NCT ID: NCT05710796 Completed - Complication Clinical Trials

AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS

Start date: September 1, 2021
Phase:
Study type: Observational

Aim of the study is to evaluate the prevalence and bring awareness ofcardiovascular complications in COVID-19 recovered patients. Study is conducted at single site, which is Srinivasa Heart Centre, Warangal, Telangana state in India for the duration of 4 months. The sample size is calculated 500 patients and the study is cohort, observational study. Patient consent has been taken before enrolment.

NCT ID: NCT05708781 Completed - Low Back Pain Clinical Trials

Efficacy of Core Strengthening and Intensive Dynamic Back Exercises in Patient With Low Back Pain

Start date: December 20, 2022
Phase: N/A
Study type: Interventional

The study aimed to investigate the efficacy of core strengthening and intensive dynamic back exercises on pain, muscle strength, endurance, and functional disability in patients with chronic non-specific low back pain.

NCT ID: NCT05702008 Completed - Rabies Clinical Trials

Social Media as an Information, Education and Communication Tool for Rabies Prevention: An Interventional Study

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Background: Rabies is a fatal disease that can be avoided by treating animal bites promptly. Hence, post-exposure prophylaxis is critical. As a result, the National Rabies Control Program was approved under the 12th five-year plan in India. One of its strategies is to engage in Information, Education and Communication activities. Social media provides an opportunity for the quick and easy dissemination of research but is constrained by a lack of peer review and the risk of misinterpretation. The efficacy of a novel social media-based knowledge dissemination strategy for rabies prevention was tested in this study. Methods: An experimental study design was followed, wherein 144 preclinical medical students of Maulana Azad Medical College, Delhi, India were included in each control and test group. The test group was administered the intervention, which exposed the participants to health education material via social media across a span of 30 days. Participants' knowledge, attitude and practices were observed before and after the study duration.

NCT ID: NCT05693415 Completed - Clinical trials for Lumbar Osteoarthritis

Primary Osteoarthritis Lumbar Spine: Establishing Its Cause, Pathogenesis and Treatment.

Start date: July 1, 2021
Phase:
Study type: Observational

The study was about a root cause of Primary Osteoarthritis Lumbar Spine producing disabilities in sitting, climbing and walking etc. In advance stage the person is bereft of his/her personal physical activities. The prevalent treatment is temporary and dis-satisfactory. A new treatment was designed and a trial was conducted on 154 patients (100 in the trial group, 50 in the control group) for a duration of six months.

NCT ID: NCT05692583 Completed - De Quervain Disease Clinical Trials

Correlation Between EPB Entrapment Test and Ultrasound Wrist Findings in Patients With deQuervain's Disease

Start date: November 1, 2020
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to learn about the correlation between EPB entrapment test and ultrasound wrist findings in patients with deQuervain's disease The main questions it aims to answer are: - if correlation exist between EPB entrapment test and ultrasound wrist findings in patients with deQuervain's disease ? - if the the correlation aid in deciding management of patients with deQuervain's disease Participants will be subjected to - EPB entrapment test - ultrasound examination of wrist

NCT ID: NCT05663749 Completed - Schizophrenia Clinical Trials

Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics

Start date: September 20, 2022
Phase: Phase 4
Study type: Interventional

Metabolic syndrome is common in patients of schizophrenia. It can add to morbidity, loss of functionality and discontinuation of antipsychotic medication. Apart from metformin, there are limited treatment options as add on-s to antipsychotics for treatment of metabolic syndrome. There have been placebo-controlled studies of Topiramate as an adjuvant but the present study would be the first head-on trial between these drugs for treatment of metabolic syndrome in patients of schizophrenia. If the outcome measures show a significant improvement with add on topiramate when compared with Metformin, then add on Topiramate can be a preferred treatment for metabolic syndrome in patients with schizophrenia on atypical antipsychotics. The adverse effects of Metformin can be side-stepped and Topiramate can also be given in conditions which are contraindications for Metformin. Thus, Topiramate can be a good alternative to metformin especially in conditions like liver, cardiac and renal impairment where metformin use should be avoided. Topiramate can not only improve metabolic parameters but can also have a beneficial effect on the symptom severity of schizophrenia. Thus, it can be a good augmentation drug to be used along with antipsychotics in these patients.

NCT ID: NCT05659537 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

Start date: December 29, 2022
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to evaluate safety of dulaglutide in participants with type 2 diabetes mellitus in India.

NCT ID: NCT05648357 Completed - Influenza, Human Clinical Trials

A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India

Start date: December 14, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to gather additional evidence of the safety and immunogenicity of 1 dose of Fluarix Tetra (0.5 milliliter [mL]) (Northern Hemisphere (NH)2023-2024) in individuals aged 65 years and above to fulfill a post-approval condition imposed by the Indian regulatory authorities (CDSCO) for this age group in India.